Tonix Pharmaceuticals: FDA AdCom News Positive, But Making Bull Case Is Problematic
Tonix Pharma (TNXP) has submitted an NDA for its candidate TNX-102 SL for fibromyalgia, with a PDUFA date set for August 15, 2025. See why I'm on the sidelines.
What Covid’s One-Hit Wonders Should Have Taught Us
Pandemic darlings had a lot in common with AI, quantum computing and 3-D printing.